Found: 71
Select item for more details and to access through your institution.
Novel Concepts in Radioimmunotherapy for Non-Hodgkin's Lymphoma.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 2, p. 203
- By:
- Publication type:
- Article
A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study).
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 6, p. 1123, doi. 10.1111/bjh.17420
- By:
- Publication type:
- Article
First‐line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)‐Medicare population‐based study.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. 222, doi. 10.1111/bjh.16525
- By:
- Publication type:
- Article
Efficacy of lenalidomide in high‐risk diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 4, p. e33, doi. 10.1111/bjh.16302
- By:
- Publication type:
- Article
Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 660, doi. 10.1111/bjh.15149
- By:
- Publication type:
- Article
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 2, p. 250, doi. 10.1111/bjh.14667
- By:
- Publication type:
- Article
Outcomes of MYC-associated lymphomas after R- CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 5, p. 686, doi. 10.1111/bjh.14100
- By:
- Publication type:
- Article
Outcomes following watchful waiting for stage II- IV follicular lymphoma patients in the modern era.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 5, p. 724, doi. 10.1111/bjh.13895
- By:
- Publication type:
- Article
Phase II trial of R- CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 2, p. 208, doi. 10.1111/bjh.13818
- By:
- Publication type:
- Article
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 530, doi. 10.1111/bjh.13634
- By:
- Publication type:
- Article
Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 2, p. 205, doi. 10.1111/bjh.13562
- By:
- Publication type:
- Article
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 1, p. 85, doi. 10.1111/bjh.13399
- By:
- Publication type:
- Article
R- CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma ( DLBCL): SWOG S0433.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 382, doi. 10.1111/bjh.12906
- By:
- Publication type:
- Article
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 4, p. 487, doi. 10.1111/bjh.12570
- By:
- Publication type:
- Article
Long‐term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial Bruton tyrosine kinase inhibitors therapy for chronic lymphocytic leukemia or lymphoplasmacytic lymphoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E288, doi. 10.1002/ajh.27038
- By:
- Publication type:
- Article
Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New Directions.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 5, p. 402
- By:
- Publication type:
- Article
Management of Marginal Zone Lymphoma.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 9, p. 840
- By:
- Publication type:
- Article
Relapsed/Refractory Diffuse Large B-cell Lymphoma: On the Threshold of New Therapies.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 615
- By:
- Publication type:
- Article
A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 10, p. e2128373, doi. 10.1001/jamanetworkopen.2021.28373
- By:
- Publication type:
- Article
Optimizing the Use of Oral Therapy in Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 8, p. 454
- By:
- Publication type:
- Article
Outcomes of Patients With Burkitt Lymphoma Older Than Age 40 Treated With Intensive Chemotherapeutic Regimens.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 4, p. 307, doi. 10.3816/CLM.2009.n.060
- By:
- Publication type:
- Article
Novel Agents for Hematologic Malignancies: An Era of Riches.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 8, p. S6
- By:
- Publication type:
- Article
Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 1, p. e2351062, doi. 10.1001/jamanetworkopen.2023.51062
- By:
- Publication type:
- Article
Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8211, doi. 10.1002/cam4.5628
- By:
- Publication type:
- Article
Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 11, p. 3059, doi. 10.1002/cam4.879
- By:
- Publication type:
- Article
Bendamustine Produces Durable Responses With an Acceptable Safety Profile in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 6, p. 452, doi. 10.3816/CLML.2010.n.079
- By:
- Publication type:
- Article
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 5, p. 978
- By:
- Publication type:
- Article
Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Healthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma Population.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. e260, doi. 10.1016/j.clml.2023.05.010
- By:
- Publication type:
- Article
Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Polatuzumab Vedotin plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Results from the Phase III POLARIX Study
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 56
- By:
- Publication type:
- Article
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 185, doi. 10.1002/hon.2838
- By:
- Publication type:
- Article
Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chemotherapy free treatment of indolent lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I/II trial of vorinostat (SAHA) in combination with rituximab‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 4, p. 486, doi. 10.1002/ajh.25010
- By:
- Publication type:
- Article
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 8, p. 770, doi. 10.1002/ajh.24401
- By:
- Publication type:
- Article
Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 8, p. 712, doi. 10.1002/ajh.22075
- By:
- Publication type:
- Article
Symptomatic intracardiac diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 10, p. 683, doi. 10.1002/ajh.21329
- By:
- Publication type:
- Article
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Radiation for diffuse large B-cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 7, p. 1032, doi. 10.1002/cncr.29113
- By:
- Publication type:
- Article
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 13, p. 1993, doi. 10.1002/cncr.28676
- By:
- Publication type:
- Article
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 12, p. 1830, doi. 10.1002/cncr.28659
- By:
- Publication type:
- Article
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: Results of the National LymphoCare Study.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 23, p. 4129, doi. 10.1002/cncr.28350
- By:
- Publication type:
- Article
Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: A comprehensive analysis from the NCCN lymphoma outcomes project.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Stem Cell Transplantation for Follicular Lymphoma Relapsed/Refractory After Prior Rituximab.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 20, p. 3662, doi. 10.1002/cncr.28243
- By:
- Publication type:
- Article
Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 19, p. 4842, doi. 10.1002/cncr.27513
- By:
- Publication type:
- Article